ISO/TR 12417-2:2017
Cardiovascular implants and extracorporeal systems — Vascular device-drug combination products — Part 2: Local regulatory information
Reference number
ISO/TR 12417-2:2017
Edición 1
2017-11
Retirada
ISO/TR 12417-2:2017
63851
Retirada (Edición 1, 2017)

Resumen

ISO/TR 12417-2:2017 provides region-specific information for

- local submissions and approvals for vascular device-drug combination products (VDDCPs) in countries and regions around the world;

- changes related to the drug containing part and how they are evaluated by the different local regions.

For implanted products, this document is considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.

ISO/TR 12417-2:2017 is considered also as a supplement to ISO 12417‑1, and any relevant device-specific standards, such as the ISO 25539 series specifying requirements for endovascular devices. Requirements listed in this document also address VDDCPs that are not necessarily permanent implants.

Informaciones generales

  •  : Retirada
     : 2017-11
    : Retirada de la Norma Internacional [95.99]
  •  : 1
     : 29
  • ISO/TC 150/SC 2
    11.040.40 
  • RSS actualizaciones

Got a question?

Check out our FAQs

Customer care
+41 22 749 08 88

Opening hours:
Monday to Friday - 09:00-12:00, 14:00-17:00 (UTC+1)